by Dr. Olivia Fletcher | Oct 16, 2024 | REMS
Kathy Bates’ revival of the iconic Matlock series has brought back the legal drama we all know and love. As much as we love the reboot, the portrayal of the opioid crisis is deeply flawed and misleading. In the pilot episode, Madeline “Maddy” Matlock suggests...
by Li-Anne Rowswell Mufson | Jun 3, 2024 | Consulting
Why your organization needs a consultant In today’s complex regulatory landscape, biotech, pharmaceutical, and medical device organizations face numerous challenges in bringing products to market while ensuring compliance with evolving standards. This is why...
by Li-Anne Rowswell Mufson | May 7, 2024 | About Metis
In the fast-paced and demanding field of Pharmaceutical development and manufacturing, there are a lot of responsibilities with life-or-death consequences for the ultimate focus of importance- the patient. Quality, Compliance, and Pharmacovigilance professionals are...
by Li-Anne Rowswell Mufson | Apr 1, 2024 | AI in Life Sciences
This Week, the Guard Rail is thrilled to have our first-ever guest blogger. Metis’ COO, Dr. Olivia Fletcher, has written a fascinating article looking deeper into AI and its use as a tool, not a replacement for human input and documentation. This comes on the...
by Li-Anne Rowswell Mufson | Mar 18, 2024 | AI in Life Sciences
Our CEO Michelleanne Bradley, will be on the Panel this week at the RIC Annual Meeting in Virginia Artificial Intelligence (AI) Applications and Considerations in REMS Programs Panel Discussion 12:45 PM – 1:45 PM The Arlington Forum Since last year’s RIC...
Recent Comments